Tandem Diabetes Care and Dexcom Announce Compatibility of t:slim X2 Insulin Pump with Dexcom G7 CGM in Canada
Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM) have announced that the updated software for the t:slim X2™ insulin pump is now compatible with both the Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) Systems, and has been authorized for sale by Health Canada. This update allows users of the t:slim X2 insulin pump with Control-IQ technology, the top-rated automated insulin delivery (AID) system in Canada,* to choose between Dexcom G7 and Dexcom G6 CGMs for managing their diabetes.
“This is the first AID system in Canada to support both Dexcom G7 and G6 CGMs, showcasing our commitment to advancing AID technology and expanding user choice,” said Mark Novara, Executive Vice President and Chief Commercial Officer of Tandem Diabetes Care.
Commercial availability of the new integration is anticipated for this fall. Existing users in Canada with an in-warranty t:slim X2 pump will receive instructions from Tandem on how to upgrade to the new software, allowing them to choose between Dexcom G7 and G6 CGMs at no additional cost. New customers will receive t:slim X2 pumps with the updated software pre-installed.
Mark Novara added, “We are excited to celebrate over a decade of partnership with Dexcom, marking this milestone that allows Canadian users to benefit from our leading insulin pump technology combined with Dexcom’s advanced CGM technology.”
André Côté, Executive Vice President and General Manager of Dexcom Canada, noted, “Studies indicate that AID systems powered by Dexcom CGM improve time in range and help reduce nighttime lows. We are thrilled that Canadians using the t:slim X2 insulin pump will soon benefit from the integration with Dexcom G7, our most accurate CGM.”
Benefits of Dexcom G7 include:
- A 60% smaller, low-profile all-in-one sensor and transmitter compared to Dexcom G6
- A 30-minute sensor warmup time
- A 12-hour grace period for sensor replacement
- Enhanced connectivity with leading digital health apps
Features of the t:slim X2 insulin pump with Control-IQ technology:
- Rated #1 AID System in Canada* with Control-IQ Technology that predicts glucose levels 30 minutes ahead and adjusts insulin automatically
- Customizable Personal Profiles and settings for Sleep and Exercise Activities
- Flexible infusion set options allowing users to disconnect from the pump conveniently
The t:slim X2 pump with Dexcom G7 integration was launched in the U.S. in December 2023 and will be introduced to additional countries in early 2024.
For more information on Tandem insulin pumps or to check coverage, visit tandemdiabetes.ca. For details on Dexcom G6 or G7, visit dexcom.com or consult your healthcare provider.
